Efficacy of immunosorption in patients with systemic lupus erythematosus: A double blind controlled trial

被引：0
|
作者：
Amosova, EN [1 ]
Yaremenko, OB [1 ]
Snezhkova, EA [1 ]
Drannik, GV [1 ]
机构：
[1] AA Bogomolets Natl Med Univ, Chair Hosp Therapy 1, Kiev, Ukraine
来源：
TERAPEVTICHESKII ARKHIV | 1997年 / 69卷 / 12期
关键词：
SLE; immunosorption; lupus nephritis; combined therapy; immune status;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Efficacy of immunosorption (IS) employing perfusion of whole blood through activated charcoal containing DNA was studied in 11 patients with systemic lupus erythematosus (SLE). 11 SLE patients exposed to hemosorption on charcoal free from DNA served as controls. When used in combination with intensive therapy (corticosteroids and cytostatic immunosuppressant), IS produced a positive effect on lupus nephritis symptoms in 8 out of 10 patients with kidney affection. AntiDNA antibodies blood level decreased by 53.6% after two IS procedures, while only by 36.4% after nonselective hemosorption. Reduced count and functional activity of B-cells recorded after IS contribute much to final outcome of the treatment.
引用
收藏
页码：18 / 22
页数：5
相关论文
共 50 条
  • [41] A RANDOMIZED DOUBLE-BLIND COMPARATIVE CLINICAL TRIALS TO EVALUATE EFFICACY OF VITAMIN D IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS
    Lomarat, W.
    Pakchotanon, R. Rattapol
    Chaiamnuay, S.
    Narongroeknawin, P.
    Asavatanabodee, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 165 - 165
  • [42] Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial
    Zimmer, Robert
    Scherbarth, Hugo R.
    Luis Rillo, Oscar
    Jesus Gomez-Reino, Juan
    Muller, Sylviane
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (11) : 1830 - 1835
  • [43] Prospective double blind randomize clinical trial comparing methotrexate (MTX) and placebo in systemic lupus erythematosus (SLE) patients.
    Carneiro, JR
    Sato, EI
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1759 - 1759
  • [44] Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial
    Merrill, Joan T.
    Tanaka, Yoshiya
    D'Cruz, David
    Vila-Rivera, Karina
    Siri, Daniel
    Zeng, Xiaofeng
    Saxena, Amit
    Aringer, Martin
    D'Silva, Kristin M.
    Cheng, Ling
    Mohamed, Mohamed-Eslam F.
    Siovitz, Lucia
    Bhatnagar, Sumit
    Gaudreau, Marie-Claude
    Doan, Thao T.
    Friedman, Alan
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (10) : 1518 - 1529
  • [45] Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
    Navarra, Sandra V.
    Guzman, Renato M.
    Gallacher, Alberto E.
    Hall, Stephen
    Levy, Roger A.
    Jimenez, Renato E.
    Li, Edmund K-M
    Thomas, Mathew
    Kim, Ho-Youn
    Leon, Manuel G.
    Tanasescu, Coman
    Nasonov, Eugeny
    Lan, Joung-Liang
    Pineda, Lilia
    Zhong, Z. John
    Freimuth, William
    Petri, Michelle A.
    LANCET, 2011, 377 (9767): : 721 - 731
  • [46] INEFFECTIVENESS OF LEVAMISOLE IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A CONTROLLED TRIAL
    HADIDI, T
    DECKER, JL
    ELNAGDY, L
    SAMY, M
    ARTHRITIS AND RHEUMATISM, 1981, 24 (01): : 60 - 63
  • [47] CONTROLLED TRIAL OF CYCLOPHOSPHAMIDE IN SYSTEMIC LUPUS-ERYTHEMATOSUS NEPHRITIS
    STEINBERG, AD
    KALTREID.HB
    STAPLES, PJ
    GOETZL, EJ
    TALAL, N
    DECKER, JL
    ARTHRITIS AND RHEUMATISM, 1970, 13 (03): : 351 - +
  • [48] Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise
    Tench, CM
    McCarthy, J
    McCurdie, I
    White, PD
    D'Cruz, DP
    RHEUMATOLOGY, 2003, 42 (09) : 1050 - 1054
  • [49] Conventional versus Rapid Glucocorticoid Tapering in Severe Systemic Lupus Erythematosus Patients: A Non-Blind, Randomized Controlled Trial
    Abe, Yoshiyuki
    Fujibayashi, Kazutoshi
    Nishizaki, Yuji
    Yanagisawa, Naotake
    Nojiri, Shuko
    Kon, Takayuki
    Tada, Kurisu
    Yamaji, Ken
    Tamura, Naoto
    ACTA MEDICA OKAYAMA, 2020, 74 (02) : 179 - 183
  • [50] EFFICACY AND SAFETY OF RITUXIMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Ren, Y.
    Wang, L.
    An, Z.
    Yang, L.
    Su, Q. Y.
    Yu, Q.
    He, P. F.
    Li, X.
    Zhang, S. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1477 - 1477
12345